CNR Institutional Research Information System

Petrosino, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 361
AS - Asia 271
EU - Europa 46
AF - Africa 5
OC - Oceania 1
SA - Sud America 1
Totale 685
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 361
SG - Singapore 253
IT - Italia 19
CN - Cina 14
FI - Finlandia 11
NL - Olanda 6
DE - Germania 4
AT - Austria 3
TN - Tunisia 3
AU - Australia 1
AZ - Azerbaigian 1
CO - Colombia 1
EE - Estonia 1
GB - Regno Unito 1
HK - Hong Kong 1
JO - Giordania 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
NG - Nigeria 1
Totale 685
Salva come PNG Salva come JPEG
Città #
Santa Clara 304
Singapore 154
Helsinki 11
Guangzhou 4
Ashburn 3
Milan 3
Naples 3
Tunis 3
Cavallino 2
Phoenix 2
Rome 2
San Salvatore Monferrato 2
Treviso 2
Vienna 2
Afragola 1
Amman 1
Amsterdam 1
Baku 1
Chongqing 1
Colombo 1
Cúcuta 1
Düsseldorf 1
Giarre 1
Hong Kong 1
Lagos 1
London 1
Los Angeles 1
New York 1
Newark 1
Nuremberg 1
San Jose 1
Tallinn 1
Vilnius 1
Totale 516
Salva come PNG Salva come JPEG
Nome #
Analysis of the oral microbiome during hormonal cycle and its alterations in menopausal women: the “AMICA” project 21
Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis 15
Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis 15
Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. 14
Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis 14
N-Palmitoylethanolamine-oxazoline (PEA-OXA): A new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an experimental model of repeated bilateral common carotid arteries occlusion 14
Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity 14
Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients. 12
Circulating endocannabinoids in insulin sensitive vs. Insulin resistant obese postmenopausal women. A MONET group study 12
Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal anti-inflammatory agent. 11
FULL INHIBITION OF SPINAL FATTY ACID AMIDE HYDROLASE IN NEUROPATHIC RATS LEADS TO TRPV1-MEDIATED ANALGESIC EFFECTS VIA REMODELING OF THE ENDOCANNABINOID SYSTEM 11
Synthesis of novel 2-(1-adamantanylcarboxamido)thiophene derivatives. Selective cannabinoid type 2 (CB2) receptor agonists as potential agents for the treatment of skin inflammatory disease 11
Phytocannabinoids promote viability and functional adipogenesis of bone marrow-derived mesenchymal stem cells through different molecular targets 10
The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels. 10
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties 10
1.Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis. 10
European Biotech Week 2020-"L'ETERNA LOTTA TRA L'UOMO E IL VIRUS". 8
Protective activation of the endocannabinoid system during ischemia in dopamine neurons. 8
Exposure to allergen causes changes in nts neural activities after intratracheal capsaicin application, in endocannabinoid levels and in the glia morphology of nts 8
Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regeneration 8
The endocannabinoid system is modulated in response to spinal cord injury in rats. 8
Interactions of non-THC phytocannabinoids and Cannabis extracts with TRP channels and endocannabinoid metabolic enzymes 7
Protective role of palmitoylethanolamide in contact allergic dermatitis 7
Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men 7
The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels 7
Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-induced atrophy in rats 7
Alteration of the endocannabinoid system in mouse brain during prion disease. 7
The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations 7
Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain 7
Functional lipidomics. Calcium-independent activation of endocannabinoid/endovanilloid lipid signalling in sensory neurons by protein kinases C and A and thrombin. 7
A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson s disease 6
Synthesis and biological evaluation of new potential inhibitors of N-acylethanolamine hydrolyzing acid amidase. 6
Gender-dependent cellular and biochemical effects of maternal deprivation on the hippocampus of neonatal rats: A possible role for the endocannabinoid system. 6
Endocannabinoids Are Endogenously Overproduced In Highly Malignant Ovarian Carcinoma: Possible Involvement Of Cox-2 In Their Tonic Control Of Cancer Spreading And Potential Pharmacological Relevancies 6
The chemotherapeutic agent cisplatin increases brain 2-arachidonoyl-glycerol (2-AG) concentrations and concomitantly reduces intestinal 2-AG and anandamide levels in a vomiting species (the least shrew). 6
LEPTIN-CONTROLLED OREXIN/ENDOCANNABINOID INTERACTIONS IN THE MOUSE PERIAQUEDUCTAL GREY: ROLE IN THE REGULATION OF THE DESCENDING ANTINOCICEPTIVE PATHWAY 6
ANANDAMIDE INJECTED INTRATHECALLY INDUCES ANALGESIA MEDIATED BY A TRPV1-DEPENDENT MECHANISM IN NEUROPATHIC RATS 6
The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice. 6
Direct and indirect modulation of cannabinoid system in a phencyclidine model of schizophrenia 6
An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis 6
The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption 6
Role and regulation of acylethanolamides in energy balance: focus on adipocytes and Ò-cells 6
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis. 6
Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding. 6
Alterations in endocnnabinoid levels accompanying parkinsonism and levodopa-induced dyskinesia in the MPTP-lesioned macaque 6
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems 6
Endocannabinoid chemical biology: a tool for the development of novel therapies 5
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels 5
CB1, but not CB2, mediates stimulation of bone formation induced by traumatic brain injury. 5
Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats 5
INVOLVEMENT OF RETINAL PROJECTIONS TO THE LATERAL HYPOTHALAMUS IN LIGHT-MEDIATED ENDOCANNABINOID SYNTHESIS: CRITICAL ROLE OF OREXINERGIC AND ENDOCANNABINOID SYSTEMS IN LIGHT-ENTRAINABLE RHYTHMS 5
FAAH inhibition elevates endocannabinoid levels in the periaqueductal grey of the rat: dual effect on nociception via CB1 and TRPV1 receptors 5
Protective role of aliamides and endocannabinoid system during »-carrageenin-induced granuloma formation. 5
Effect of N-arachidonoylserotonin (AA-5-HT), a FAAH inhibitor with antagonistic activity at vanilloid TRPV1 receptor, in an animal model of acute inflammation. 5
Regulation, function and dysregulation of endocannabinoids in models of adipose and b-pancreatic cells and in obesity and hyperglycemia 5
Protective role of palmitoylethanolamide in keratinocytes and its involvement in contact allergic dermatitis. 5
Attenuation of allergic contact dermatitis through the endocannabinoid system. 5
Regulation of hypothalamic endocannabinoid levels by neuropeptides and hormones involved in food intake and metabolism: insulin and melanocortins 5
ACTIVATION OF SPINAL TRPV1 OR CB1 RECEPTORS IN NEUROPATHIC RATS DEPENDS ON ANANDAMIDE CONCENTRATION 5
ALTERATIONS OF BASAL AND FASTING/REFEEDING-REGULATED TISSUE LEVELS OF ENDOGENOUS N-ACYL-ETHANOLAMINE LIGANDS OF PPAR-± ESE ZUCKER RATS 5
LIVER AND ADIPOSE TISSUE ENDOCANNABINOID TONE IN DIET-INDUCEDOBESITY IS DEPENDENT ON APOLIPOPROTEIN E EXPRESSION ANDASSOCIATED WITH HEPATIC STEATOSIS AND INSULIN RESISTANCE 5
Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets 5
From endocannabinoid profiling to 'endocannabinoid therapeutics' 5
Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both CB1 and TRPV1 receptors 5
Increasing cannabinoid levels by pharmacological and genetic manipulation delays disease progression in SOD1 mice 5
Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine. 5
Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels 5
Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels 5
Anandamide and AM251, via water, modulate food intake at central and peripheral level in fish 5
Alterations of endocannabinoid and acylethanolamide levels in peripheral tissues of mice on a high fat diet: implications for gastric emptying and metabolism. 5
Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-fos expression in the hypothalamus 5
Anti-inflammatory effect of palmitoylethanolamide on human adipocytes. 5
The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy. 5
A gradient of 2-arachidonoylglycerol regulates mouse epididymal sperm cell start-up. 5
Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors. 5
Neonatal stress-induced neurodegeneration: a suitable animal model to evaluate neuroprotective and modulatory properties of cannabinoids. 5
Endocannabinoids and the regulation of their levels in health and disease 5
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes 5
Palmitoylethanolamide counteracts reactive astrogliosis induced by beta-amyloid peptide 5
POTENTIAL OXIDATION OF 2-AG BY COX-2 ENHANCES MALONATE TOXICITY IN THE STRIATUM: RELEVANCE FOR CANNABINOID TREATMENTS IN HUNTINGTON S DISEASE 5
Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide 5
Inhibition of basal and ultraviolet B-induced melanogenesis by cannabinoid CB(1) receptors: a keratinocyte-dependent effect. 5
Differential control by GQ/G11 proteins of in vivo endocannabinoid levels and endocannabinoid-mediated regulation of neuronal excitability. 5
POSSIBLE ENTOURAGE EFFECT OF PALMITOYLETHANOLAMIDE IN DOG AND HUMAN PLASMA 5
Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100 ² up-regulation in vitro 4
Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes 4
INSULIN AS A NEGATIVE REGULATOR OF PLASMA ENDOCANNABINOID LEVELS IN OBESE AND NONOBESE SUBJECTS 4
Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia 4
Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo. 4
Effect of inhibitors of endocannabinoid uptake and FAAH on brain endocannabinoid levels. 4
Impaired endocannabinoid levels in selected brain areas of transgenic R6/2 mice, and experimental model of Huntington s disease. 4
The endocannabinoid system is activated in response to spinal cord injury in rats. 4
Attenuation of allergic contact dermatitis through the endocannabinoid system 4
Overactivation of the endocannabinoid system in human endometrial carcinoma. 4
Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects 4
CB2 receptors in mouse male germ cell differentiation 4
Endocannabinoid and orexin-1 interactions in the hypothalamus: one possibile clue to obesity 4
Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington's disease 4
The levels of the endocannabinoid receptor CB2 and its ligand 2-Arachidonoylglycerol are elevated in endometrial carcinoma. 4
N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities. 4
Totale 657
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.548
article - articoli 2.608
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.156
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202419 0 0 0 0 0 0 0 0 4 0 10 5
2024/2025670 5 11 148 65 302 21 7 88 23 0 0 0
Totale 689